These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29240034)

  • 21. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma.
    Peng S; Yang K; Xu Z; Chen S; Ji Y
    J Paediatr Child Health; 2019 Sep; 55(9):1119-1124. PubMed ID: 30604513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
    Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M
    Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis.
    Putra J; Gupta A
    Pathology; 2017 Jun; 49(4):356-362. PubMed ID: 28438388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
    Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
    Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis.
    Sobrino-Fernández E; Campos-Domínguez M; Gregorio-Hernández R; Huerta-Aragonés J; Beléndez-Bieler C; Lancharro-Zapata Á; Franco-Fernández ML; Bernardo-Atienza B; Sánchez-Luna M
    Pediatr Dermatol; 2017 May; 34(3):e128-e129. PubMed ID: 28318049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms.
    Iacobas I; Simon ML; Amir T; Gribbin CE; McPartland TG; Kaufman MR; Calderwood S; Nosher JL
    Clin Imaging; 2015; 39(3):529-32. PubMed ID: 25662209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y; Chen S; Yang K; Xia C; Peng S
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H; Guo X; Duan Y; Zheng B; Gao Y
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus.
    Dang N; Ren Y
    Vasc Health Risk Manag; 2024; 20():251-254. PubMed ID: 38883398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
    Zhang X; Yang K; Chen S; Ji Y
    J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Case Report of 2 Sirolimus-Related Deaths Among Infants With Kaposiform Hemangioendotheliomas.
    Ying H; Qiao C; Yang X; Lin X
    Pediatrics; 2018 Apr; 141(Suppl 5):S425-S429. PubMed ID: 29610165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.
    Barabash-Neila R; García-Rodríguez E; Bernabeu-Wittel J; Bueno-Rodríguez I; Ramírez-Villar G; López-Gutierrez JC
    Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581
    [No Abstract]   [Full Text] [Related]  

  • 33. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
    Garcia-Monaco R; Giachetti A; Peralta O; Napoli N; Lobos P; Gioseffi L; Mariani G
    J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypically presenting kaposiform hemangioendothelioma of the knee: ultrasound findings.
    Erdem Toslak I; Stegman M; Reiter MP; Barkan GA; Borys D; Lim-Dunham JE
    J Med Ultrason (2001); 2018 Oct; 45(4):653-656. PubMed ID: 29637402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
    Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Refractory Mandibular Kaposiform Hemangioendothelioma with Sirolimus: A Case Report and Review of the Literature.
    Rikhotso RE; Alharbi AA
    J Oral Maxillofac Surg; 2021 Oct; 79(10):2086.e1-2086.e8. PubMed ID: 34153244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumocystis jirovecii pneumonia: A potential complication of sirolimus therapy.
    Shetty AK
    J Paediatr Child Health; 2019 Apr; 55(4):484. PubMed ID: 30957331
    [No Abstract]   [Full Text] [Related]  

  • 38. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
    Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY
    Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
    Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
    Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
    Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
    Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.